Just start calling these emerging substances like drugs is not because of the new creation of a toxic substance but by the appearance as new of a known substance, or used for other purposes or which often are reappearances substances previously known and used. These substances most often are not included in the lists of drugs or illegal substances. Research chemicals are also known as “JWH-018 for sale“,
Patient Groups Applaud Senators for Raising Critical Patient Safety Questions about Biosimilars PBSA calls for additional oversight and committee hearing to address patient safety concerns (May 01, 2015) Patients for…
Senate health committee chair Lamar Alexander (R-TN) led a group of Republican senators lines in expressing anxiety about unresolved questions concerning FDA’s implementation of the biosimilar pathway, saying the agency’s “failure” to resolve fundamental questions